Business Segments · Lead product project expenses
Business Segments — Lead product project expenses
Schering-Plough Business Segments — Lead product project expenses remained flat by 0.0% to $3.98M in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 12.0%, from $3.55M to $3.98M.
Analysis
StatementSegment
CategoryGrowth
SignalContext dependent
VolatilityModerate
First reportedQ1 2024
Last reportedQ4 2025
How to read this metric
Increases generally reflect the progression of clinical trials or manufacturing scale-up, which are critical for long-term value creation.
Detailed definition
Direct costs associated with the research, development, and clinical trial activities of the segment's primary product c...
Peer comparison
Comparable to 'Research and Development' expenses focused on specific pipeline assets at other biopharma companies.
Metric ID:
sgp_segment_reporting_segment_lead_product_project_expensesHistorical Data
2 years
| FY'24 | FY'25 | |
|---|---|---|
| Value | $14.21M | $15.92M |
| YoY Change | — | +12.0% |
Range$14.21M – $15.92M
Avg YoY Growth+12.0%
Median YoY Growth+12.0%
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Schering-Plough's business segments — lead product project expenses?
- Schering-Plough (SGP) reported business segments — lead product project expenses of $3.98M in Q4 2025.
- How has Schering-Plough's business segments — lead product project expenses changed year-over-year?
- Schering-Plough's business segments — lead product project expenses increased by 12.0% year-over-year, from $3.55M to $3.98M.
- What does business segments — lead product project expenses mean?
- The direct costs of developing the segment's main product candidate.